NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BioLumic

BioLumic

Private
Palmerston NorthHealthcare & Life Scienceshttps://www.biolumic.com/

Last Round

Series B

Extension

Apr 22, 2025

Total Funding Raised

$28.3M

Company Overview

BioLumic is an agritech company that provides a crop improvement system using ultraviolet light to improve plant productivity.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Supply Chain

Business Model

B2B

Customer Profile

Revenue Share, Hardware + Subscription, Services & Consulting

AI Layer

Non-AI

Keywords

UV seed treatmentagricultural biotechnologynon-GMO trait enhancementseed programmingtrait licensingcrop yield improvementAgTechphotobiologyseed enhancementcrop resilienceagricultural epigeneticstrait activationlight recipes

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioLumic Comps

Public and private peers based on sector, stage, and business model.

BioLumic comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BioLumic Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionApr 22, 2025
Series BJun 21, 2022
Series A ExtensionMay 15, 2019
Series AMar 16, 2018
SeedOct 1, 2014

Key People

Founding team and executive leadership

Jason Wargent

Chief Science Officer & Founder Of BioLumic Ltd

Founding Team

Steve Sibulkin

Chief Executive Officer And Board Member

Executive Team

Richard Perry

Chief Financial Officer

Executive Team

Greg Levow

Chief Operating Officer

Executive Team

BioLumic Investors

Notable investors and investment history

BioLumic investors
InvestorRounds
Icehouse VenturesSeries B, Series B Extension
MIG AngelsSeries B, Series B Extension
iSelect FundSeries B Extension
RIV CapitalSeries A Extension, Series B
Bravos CapitalSeries B
Virtu Capital PartnersSeries B
Radicle GrowthSeries A Extension, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 11, 2025

    Monthly visitors grew 3425% MoM, from 28 to 987.

  • Jul 2, 2025

    Monthly visitors increased 544% to 5.3K.

BioLumic Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BioLumic Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioLumic's valuation, stock price, and market status.

Firmographic Details

HeadquartersPalmerston North
Employee Range36
Year Founded2012
Last FundingApr 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.